The enhanced dependence on the BMP/SMAD1/5/9 pathway in SMAD4-deficient contexts could potentially explain why CHRDL1 exhibits more pronounced metastasis-suppressing effects in pancreatic cancer (34). The gene discussed is SMAD1; the disease is familial pancreatic carcinoma.